Jinghua Pharmaceutical Group Co., Ltd.

XSEC:002349 Stock Report

Market Cap: CN¥6.5b

Jinghua Pharmaceutical Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Yunzhong Zhou

Chief executive officer

CN¥971.9k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.4%
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO

Yunzhong Zhou (60 yo)

no data

Tenure

CN¥971,900

Compensation

Mr. Yunzhong Zhou serves as a General Manager at Nantong Jinghua Pharmaceutical Co., Ltd and serves as its Non-Independent Director and Vice Chairman.

Board Members

NamePositionTenureCompensationOwnership
Yunzhong Zhou
GM & Vice Chairmanno dataCN¥971.90k0.36%
CN¥ 23.2m
Yuxiang Wu
Executive VP3.8yrsCN¥857.00kno data
Jianqiao Zhang
Non-Independent Director3.8yrsno datano data
Hongyu Yin
Chairman5.7yrsno datano data
Qiaogen Feng
Independent Director5.1yrsCN¥90.00kno data
Ling Ma
Independent Director3.8yrsCN¥90.00kno data
Xu Wang
Independent Director3.8yrsCN¥90.00kno data
Jian Qin
Non-Employee Supervisor3.8yrsno datano data
Jing Liu
Independent Directorless than a yearno datano data
Jian Cheng
Non Independent Directorless than a yearno datano data
Xiaomei Zhang
Independent Directorless than a yearno datano data

3.8yrs

Average Tenure

53yo

Average Age

Experienced Board: 002349's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 22:03
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jinghua Pharmaceutical Group Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wenxin YuChina Investment Securities
Ye Hui YangHuatai Research
Wen Qing WeiShenwan Hongyuan Securities